Skip to Content

Tiludronate use while Breastfeeding

Drugs containing Tiludronate: Skelid

Medically reviewed by Drugs.com. Last updated on May 31, 2020.

Tiludronate Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because no information is available on the use of tiludronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of tiludronate by a breastfed infant is unlikely.

Drug Levels

Tiludronate is highly bound to calcium and is poorly absorbed orally (average in adults 6% on an empty stomach, 0.6% with food), so absorption of tiludronate by a breastfed infant is unlikely.

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Pamidronate

Substance Identification

Substance Name

Tiludronate

CAS Registry Number

89987-06-4

Drug Class

  • Breast Feeding
  • Lactation
  • Bisphosphonates
  • Bone Density Conservation Agents
  • Diphosphonates

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

More about tiludronate

Consumer resources

Other brands
Skelid

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.